Patents by Inventor Melanie Glossop

Melanie Glossop has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds and therapeutics uses thereof
    Patent number: 11766483
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and infectious diseases, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Grant
    Filed: April 6, 2018
    Date of Patent: September 26, 2023
    Assignee: CENTAURI THERAPEUTICS LIMITED (GB/GB)
    Inventors: Michael Westby, Melanie Glossop, Christine Watson, Christopher Pickford
  • LACTAM-MODIFIED ADENO-ASSOCIATED VIRUS VECTORS
    Publication number: 20220380803
    Abstract: The present invention relates to adeno-associated virus (AAV) vectors modified by the covalent coupling of at least one compound comprising a lactam moiety (e.g., ?-lactam) to at least one amino group of an amino acid residue of the capsid of the AAV vectors. The AAV vectors are useful in transducing a cell, especially for gene therapy.
    Type: Application
    Filed: May 11, 2022
    Publication date: December 1, 2022
    Inventors: Willem Broekaert, Melanie Glossop, Karl Gibson, Nicolas Ferry, Gaëlle Lefèvre
  • NOVEL COMPOUNDS AND THERAPEUTICS USES THEREOF
    Publication number: 20220313776
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a pathogen, to the use of said compounds in a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: June 13, 2022
    Publication date: October 6, 2022
    Inventors: Michael Westby, Melanie GLOSSOP, Christine WATSON
  • Compounds and therapeutics uses thereof
    Patent number: 11406683
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a pathogen, to the use of said compounds in a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Grant
    Filed: May 4, 2018
    Date of Patent: August 9, 2022
    Assignee: CENTAURI THERAPEUTICS LIMITED (GB/GB)
    Inventors: Michael Westby, Melanie Glossop, Christine Watson
  • NOVEL COMPOUNDS AND THERAPEUTIC USES THEREOF
    Publication number: 20220162262
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a pathogen, to the use of said compounds in a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: April 1, 2020
    Publication date: May 26, 2022
    Inventors: Melanie GLOSSOP, Christine WATSON
  • COMPOUNDS AND THERAPEUTIC USES THEREOF
    Publication number: 20210369850
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: March 1, 2021
    Publication date: December 2, 2021
    Inventors: Christopher Pickford, Christine WATSON, Melanie GLOSSOP
  • COMPOUNDS AND THERAPEUTIC USES THEREOF
    Publication number: 20210353765
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and infectious diseases, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: October 10, 2019
    Publication date: November 18, 2021
    Inventors: Michael WESTBY, Melanie GLOSSOP, Christopher PICKFORD, Christine WATSON
  • COMPOUNDS AND THERAPEUTIC USES THEREOF
    Publication number: 20210346514
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and infectious diseases, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: October 10, 2019
    Publication date: November 11, 2021
    Inventor: Melanie GLOSSOP
  • Compounds and therapeutics uses thereof
    Patent number: 11130730
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and infectious diseases, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Grant
    Filed: April 6, 2018
    Date of Patent: September 28, 2021
    Assignee: CENTAURI THERAPEUTICS LIMITED (GB/GB)
    Inventors: Melanie Glossop, Christine Watson
  • Compounds and therapeutics uses thereof
    Patent number: 11014966
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a pathogen, to the use of said compounds in a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Grant
    Filed: September 13, 2017
    Date of Patent: May 25, 2021
    Assignee: CENTUARI THERAPEUTICS LIMITED
    Inventors: Melanie Glossop, Christine Watson, Michael Westby
  • IMMUNITY LINKER MOLECULES AND THEIR USE IN THE TREATMENT OF INFECTIOUS DISEASES
    Publication number: 20210085798
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a pathogen, to the use of said compounds in a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: March 14, 2019
    Publication date: March 25, 2021
    Applicant: Centauri Therapeutics Limited
    Inventors: Melanie GLOSSOP, Christine WATSON
  • Compounds and therapeutic uses thereof
    Patent number: 10953100
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Grant
    Filed: October 7, 2016
    Date of Patent: March 23, 2021
    Assignee: CENTUARI THERAPEUTICS LIMITED (GB/GB)
    Inventors: Christopher Pickford, Christine Watson, Melanie Glossop
  • NOVEL COMPOUNDS AND THERAPEUTICS USES THEREOF
    Publication number: 20200231538
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and infectious diseases, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: April 6, 2018
    Publication date: July 23, 2020
    Inventors: Melanie GLOSSOP, Christine WATSON
  • NOVEL COMPOUNDS AND THERAPEUTICS USES THEREOF
    Publication number: 20200147236
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and infectious diseases, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: April 6, 2018
    Publication date: May 14, 2020
    Inventors: Michael Westby, Melanie GLOSSOP, Christine WATSON, Christopher Pickford
  • NOVEL COMPOUNDS AND THERAPEUTICS USES THEREOF
    Publication number: 20200069767
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a pathogen, to the use of said compounds in a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: May 4, 2018
    Publication date: March 5, 2020
    Inventors: Michael Westby, Melanie GLOSSOP, Christine WATSON
  • NOVEL COMPOUNDS AND THERAPEUTICS USES THEREOF
    Publication number: 20190248838
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a pathogen, to the use of said compounds in a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: September 13, 2017
    Publication date: August 15, 2019
    Applicant: Centauri Therapeutics Limited (GB/GB)
    Inventors: Melanie GLOSSOP, Christine WATSON, Michael WESTBY
  • COMPOUNDS AND THERAPEUTIC USES THEREOF
    Publication number: 20180280521
    Abstract: The invention relates to novel compounds with the ability to link an immune response to a defined therapeutic target, to the use of said compounds in treating cancer and a disease or disorder mediated and/or caused by an infective agent, to compositions containing said compounds, processes for their preparation and to novel intermediates used in said process.
    Type: Application
    Filed: October 7, 2016
    Publication date: October 4, 2018
    Inventors: Christopher PICKFORD, Christine WATSON, Melanie GLOSSOP
  • Pyrazine Derivatives
    Publication number: 20070105872
    Abstract: The present invention relates to compounds of the formula and pharmaceutically acceptable salts and solvates thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds for the treatment of pain.
    Type: Application
    Filed: November 3, 2006
    Publication date: May 10, 2007
    Inventors: Stephen Denton, Karl Gibson, Melanie Glossop, Mark Kemp, Cedric Poinsard